Target intelligence / Profile preview

Bacterial pili and fimbriae (Pili/Fimbriae)

Target
Pili/Fimbriae
Molecular classification
Surface protein, Adhesin, Virulence factor, Chaperone-usher pathway protein
01

Overview

Bacterial pili and fimbriae are hair-like proteinaceous appendages extending from the surface of Gram-negative bacteria, serving as critical virulence factors in multidrug-resistant (MDR) pathogens (Busch & Waksman, 2012). These structures primarily function as adhesins, mediating the specific attachment of bacteria to host cell receptors, which is the essential first step for colonization and infection (Sauer et al., 2000). In pathogens such as uropathogenic Escherichia coli (UPEC) and Klebsiella pneumoniae, pili facilitate the formation of biofilms and the invasion of host tissues, protecting the bacteria from the immune system and antibiotic treatment (Totsika, 2017). Because these structures are vital for pathogenesis but not for bacterial survival, they are considered high-priority targets for anti-adhesion therapies (Spaulding et al., 2017). Therapeutic agents like mannosides (e.g., sibofimloc) and pilicides are designed to competitively inhibit adhesin binding or disrupt the assembly of the pili via the chaperone-usher pathway (Enterome, 2018). This anti-virulence strategy aims to disarm pathogens without exerting the strong selective pressure for resistance associated with traditional bactericidal antibiotics.

Other names
AdhesinsFimbrial adhesinsType 1 piliP piliType IV piliCurliAttachment piliChaperone-usher pili
02

Mechanism of action

Inhibition of bacterial adhesion to host cells by competitively binding to fimbrial adhesins (e.g., FimH) or disrupting the assembly of pili via the chaperone-usher pathway, thereby preventing colonization and biofilm formation.

03

Biological functions

Cell adhesionBiofilm formationBacterial colonizationTwitching motilityHorizontal gene transfer (Conjugation)Host cell invasion
04

Disease associations

InfectionUrinary tract infectionRespiratory tract infectionSepsisMultidrug-resistant (MDR) bacterial infectionCrohn's disease (associated with AIEC)
05

Safety considerations

Disruption of commensal microbiotaTarget specificity between pathogenic and non-pathogenic strainsPotential for compensatory expression of alternative adhesinsPharmacokinetic challenges in reaching mucosal surfaces
06

Interacting drugs

Sibofimloc (EB8018)

4 more in the full profile.

07

Biomarkers

FimH expression levelsPresence of fimH or papG genesBacterial adhesion capacityBiofilm formation index

Beyond the preview

Go deeper on Bacterial pili and fimbriae (Pili/Fimbriae).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial pili and fimbriae (Pili/Fimbriae).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call